1. Home
  2. IE vs AUPH Comparison

IE vs AUPH Comparison

Compare IE & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ivanhoe Electric Inc.

IE

Ivanhoe Electric Inc.

HOLD

Current Price

$9.25

Market Cap

2.1B

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$17.23

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IE
AUPH
Founded
2020
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
IE
AUPH
Price
$9.25
$17.23
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$18.17
$17.25
AVG Volume (30 Days)
2.3M
1.4M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
5075.00
EPS
N/A
0.25
Revenue
$3,244,000.00
$283,055,000.00
Revenue This Year
$44.79
$17.54
Revenue Next Year
$16.22
$15.74
P/E Ratio
N/A
$70.20
Revenue Growth
11.82
20.38
52 Week Low
$8.50
$7.29
52 Week High
$21.55
$19.25

Technical Indicators

Market Signals
Indicator
IE
AUPH
Relative Strength Index (RSI) 30.81 55.23
Support Level N/A $14.37
Resistance Level $15.18 N/A
Average True Range (ATR) 0.72 0.70
MACD -0.20 0.16
Stochastic Oscillator 2.23 38.62

Price Performance

Historical Comparison
IE
AUPH

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: